VAD
This multicenter cohort study evaluated the impact of preoperative temporary mechanical circulatory support (tMCS) on outcomes in patients with defined right ventricular dysfunction (RVD) undergoing HeartMate 3 left ventricular assist device (LVAD) implantation. Analyzing 201...
This session features Mark S. Slaughter, Professor and Chair of the Department of Cardiovascular and Thoracic Surgery and Medical Director of the Cardiovascular Innovation Institute at the University of Louisville,...
This multicenter cohort study evaluated the impact of preoperative temporary mechanical circulatory support (tMCS) on outcomes in patients with defined right ventricular dysfunction (RVD) undergoing HeartMate 3 left ventricular assist...
This study analyzed 3,394 pediatric congenital heart disease (CHD) patients listed for heart transplant from 2014 to 2023. Of these, 16.5 percent received ventricular assist device (VAD) support while waitlisted....
The opening manuscript on the expected series of American Society of Nuclear Cardiology Imaging Indications. For the cardiovascular surgeon, Tables 2 and 7 offer an update on the use of...
Today, The Society of Thoracic Surgeons published the third annual Pediatric Interagency Registry for Mechanical Circulatory Support (PEDIMACS) report. Between Sep 19, 2012 and Dec 31, 2017, 423 patients (less...
In the February issue of The Annals, The Society of Thoracic Surgeons published the first annual report after the Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs) joined the STS...
In a letter to healthcare providers, the US FDA summarized a recent evaluation of a postapproval study of the Abiomed Impella RP system. In clinical trials, 73% of patients survived...
Garbade and colleagues compared outcomes reported during the European Conformity (CE) Mark clinical trial of the HeartMate 3 left ventricular assist device (LVAD) to outcomes for patients treated since the...
Netuka provides several important technical nuances to consider when implanting the HeartMate 3 left heart assist device. He focuses on apical cuff attachment, optimal positioning of the pump in the...
A post-market study (ELEVATE registry) of the fully magnetically levitated continuous flow HeartMate III left ventricular assist device (LVAD) found no pump thrombosis in 463 patients in Europe and Kazakhstan....
Will await the full paper to test the titular preliminary assertion.
...Patient Care and General Interest Screening infants for critical congenital heart disease at birth is becoming mandatory in the US state of Idaho and the Indian state of Kerala. Tufts...


